Andreas Hock, PhD

AstraZeneca, England, United Kingdom

After joining AstraZeneca in 2018 as Senior Scientist in Assay Development supporting several projects across the oncology portfolio, moved on to the mechanism and profiling team as Associated Principal Scientist, focussing on mechanism of action studies and profiling support and capability development in the degrader space. I was appointed as associate Director for cellular assay development in 2020 and Director for assay development in 2021.

Disclosure information not submitted.

Presentation(s):

• High Dimensional Experimental Design (HDED) and novel cell-based assay approaches to accelerate drug discovery

  Tuesday, February 6, 2024
  11:00 AM – 11:30 AM EST